Literature DB >> 7632961

Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.

A F Gombart1, R Morosetti, C W Miller, J W Said, H P Koeffler.   

Abstract

The tumor suppressor genes p16INK4A and p15INK4B map to the 9p21 chromosomal locus and are either homozygously deleted or mutated in a wide range of human cancer cell lines and tumors. Although chromosome 9 abnormalities have been described in non-Hodgkin's lymphomas (NHLs), to date, the mutational status of these genes has not been determined for these malignancies. A total of five cell lines and 75 NHLs were examined for homozygous deletions or point mutations in the coding regions of both the p15 and p16 genes using Southern blot and/or polymerase chain reaction-single-strand conformation polymorphism analyses. Homozygous deletions of either the p16 gene or both the p15 and p16 genes were observed in one diffuse large B-cell lymphoma cell line and two uncultured lymphomas consisting of one large B-cell and one mixed T-cell lymphoma. In contrast, point mutations were not detected in either the cell lines or lymphomas. These results indicate that the rate of alterations in the p15 and p16 genes is low for lymphomas, but loss of p16 and/or p15 may be involved in the development of some lymphomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632961

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

2.  BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Authors:  Leandro C Cerchietti; Katerina Hatzi; Eloisi Caldas-Lopes; Shao Ning Yang; Maria E Figueroa; Ryan D Morin; Martin Hirst; Lourdes Mendez; Rita Shaknovich; Philip A Cole; Kapil Bhalla; Randy D Gascoyne; Marco Marra; Gabriela Chiosis; Ari Melnick
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

3.  Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.

Authors:  R Villuendas; M Sánchez-Beato; J C Martínez; A I Saez; B Martinez-Delgado; J F García; M S Mateo; L Sanchez-Verde; J Benítez; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.

Authors:  I C Navas; P L Ortiz-Romero; R Villuendas; P Martínez; C García; E Gómez; J L Rodriguez; D García; F Vanaclocha; L Iglesias; M A Piris; P Algara
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.

Authors:  F Kreisel; S Kulkarni; R T Kerns; A Hassan; H Deshmukh; R Nagarajan; J L Frater; A Cashen
Journal:  Cancer Genet       Date:  2011-03

Review 6.  Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors:  Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2016-08-01       Impact factor: 7.842

7.  Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line.

Authors:  Sun-Young Kim; Kyung-Yil Lee; Dae-Chul Jeong; Hak-Ki Kim
Journal:  Korean J Pediatr       Date:  2010-07-31

8.  Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions.

Authors:  T Kumanishi; S Zhang; T Ichikawa; S Endo; K Washiyama
Journal:  Jpn J Cancer Res       Date:  1996-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.